HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.
Rui SoaresGraça RochaAntónio Meliço-SilvestreTeresa GonçalvesPublished in: Reviews in medical virology (2016)
Over the last 30 years, research into HIV has advanced the knowledge of virus genetics and the development of efficient therapeutic strategies. HIV-1 viral protein R (Vpr) is a specialized and multifunctional protein that plays important roles at multiple stages of the HIV-1 viral life cycle. This protein interacts with a number of cellular and viral proteins and with multiple activities including nuclear transport of the pre-integration complex (PIC) to the nucleus, transcriptional activation, cell cycle arrest at G2/M transition phase and induction of cell death via apoptosis. Specifically, Vpr has been shown to control many host cell functions through a variety of biological processes and by interaction with several cellular pathways. The different functions of Vpr may enhance viral replication and impair the immune system in HIV-1 infected patients. Importantly, functional defects induced by mutations in the Vpr protein correlate with slow disease progression of HIV-infected patients. Vpr is also associated with other concomitant pathologies developed by these patients, which may lead it to be considered as a potential novel therapeutic target. This review will focus on HIV-1 Vpr, mainly on the importance of its structural mutations on the progression of HIV infection, associated phenotypes and relevance for clinical pathologies. Copyright © 2016 John Wiley & Sons, Ltd.
Keyphrases
- antiretroviral therapy
- hiv infected patients
- hiv infected
- hiv positive
- human immunodeficiency virus
- cell death
- hiv aids
- cell cycle arrest
- hiv testing
- sars cov
- hepatitis c virus
- protein protein
- binding protein
- amino acid
- newly diagnosed
- prognostic factors
- stem cells
- life cycle
- south africa
- palliative care
- cell proliferation
- heat shock protein
- heat stress